Empaglifozin cardiovascular benefit: can we separate fact from fiction?

Authors

  • Robson Brandão Silva Brazilian Society of Cardiology

DOI:

https://doi.org/10.17267/2675-021Xevidence.v1i1.2095

Downloads

Download data is not yet available.

Published

2019-06-04

How to Cite

Silva, R. B. (2019). Empaglifozin cardiovascular benefit: can we separate fact from fiction?. Journal of Evidence-Based Healthcare, 1(1), 43–45. https://doi.org/10.17267/2675-021Xevidence.v1i1.2095

Issue

Section

Critical Appraisal of Evidence